ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT05451771 updates: 1. completion date: 2026-09-01 → 2027-09-01 2. primary completion date: 2026-09-01 → 2027-09-01
Clinical trial NCT05451771 updates: 1. completion date: 2026-09-01 → 2027-09-01 2. primary completion date: 2026-09-01 → 2027-09-01
📉 **NEGATIVE** • Medium confidence analysis (71%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (19%) **Content type:** Clinical